Additional file 1 of Increased risk of contralateral breast cancer for BRCA1/2 wild-type, high-risk Korean breast cancer patients: a retrospective cohort study

Additional file 1: Table S1. The acceptance rate of BRCA tests conducted based on different testing criteria. Table S2. Description: 5-year and 10-year overall survival in each group. Table S3. 5-year and 10-year cumulative incidence of contralateral breast cancer

Univariate and multivariate analyses for determining SUV_max using ≥ 10% for AR positivity.

AR: androgen receptor. (DOCX)</p

Patient characteristics.

Patient characteristics.</p

Univariate and multivariate analyses for determining SUV_max.

Univariate and multivariate analyses for determining SUVmax.</p

Correlations of AR with expression of FA β-oxidation-associated genes and GLUT1.

AR expression show positive correlation with FA oxidation (A) and negative correlation with GLUT1 expression (B). AR, expression level of androgen receptor gene; FA, fatty acid; FA oxidation, gene set enrichment score of FA β-oxidation-associated genes; GLUT1, expression level of GLUT1 (SLC2A1) gene.</p

SUV_max according to androgen receptor status with varying cutoff values for androgen receptor positivity.

AR: androgen receptor. (DOCX)</p

Additional file 1 of PHLI-seq: constructing and visualizing cancer genomic maps in 3D by phenotype-based high-throughput laser-aided isolation and sequencing

Supplementary notes, supplementary figures, and supplementary tables. (DOCX 19232 kb

FDG uptake according to various clinicopathologic factors.

FDG uptake according to various clinicopathologic factors.</p

Representative immunohistochemistry images of AR expression.

(A) AR expression < 1%, (B) 3%, (C) 65%, (D) 90%.</p

Glycolysis-related genes from the REACTOME_GLYCOLYSIS.

(DOCX)</p